PLK1 and neoplasm: PLK1 and MYC create a positive feedforward activation loop that sustains a high expression, and PLK1 inhibitors induce apoptosis in MYC-overexpressing tumor cells, highlighting their potential as therapeutics for MYC-dependent cancers [159].